Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Filings indexed 638 across all filing types
Latest filing 2017-11-27 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Interim MD&A - French.pdf
Regulatory Filings
2017-11-27 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2017-11-27 English
News release - English.pdf
Regulatory Filings
2017-11-27 English
Material change report - English.pdf
Regulatory Filings
2017-11-02 English
News release - French.pdf
Regulatory Filings
2017-11-01 English
News release - English.pdf
Regulatory Filings
2017-11-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.